In 2024, Eli Lilly and Co (LLY.US) shines brightly while Novo-Nordisk A/S (NVO.US) fades into the background.

As the year comes to a close, Wall Street has listed Eli Lilly and Co (LLY.US) as one of the best-performing companies among large pharmaceutical firms, while Novo-Nordisk A/S (NVO.US) has lagged due to a bleak outlook.

Zhitong Finance46minutes ago

Eli Lilly to End 2024 Among Best in Big Pharma; Novo Among Worst

Seeking AlphaDec 28 09:05 ET

Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic

BenzingaDec 28 00:25 ET

Behind the Scenes of Novo Nordisk's Latest Options Trends

BenzingaDec 27 09:45 ET

Here's Why Novo Nordisk A/S (NVO) Slid in Q3

Yahoo FinanceDec 27 09:30 ET

US MOVERS&SHAKERS Dec 23-Dec 27, 2024

Moomoo NewsDec 27 03:15 ET · Markets